The solution is here — in your DNA

Genetic factors can account for up to 95% of drug-response variability and susceptibility.3 In other words, how a drug will—or won't—work for a particular individual. Our RightMed® test brings pharmacogenomics to everyone, identifying how a patient's DNA and current medications may affect their response to drugs. OneOme: making prescriptions personal.

Leaders in individualized medicine

The OneOme® platform was co-developed and exclusively licensed from Mayo Clinic to bring pharmacogenomics into routine clinical care. The OneOme RightMed pharmacogenomic test is currently in use by Mayo Clinic Center for Individualized Medicine.

Healthcare of the future.
Available today.

Cost-effective, comprehensive, personalized pharmacogenomic analysis — integrated into patients' everyday clinical care.
OneOme helps healthcare providers choose the optimal drug therapy the first time, thanks to targeted and evidence-based inputs using each patient's DNA and current prescriptions.

While OneOme can help with any prescription decision, it's particularly meaningful for patients with:

  • oneome-brain
  • oneome-cancer-ribbon
  • oneome-pain-symbol
  • oneome-cross

Learn more about OneOme's comprehensive products >

It's easy:
Swab. Send. Know.


Ordered by your physician, the OneOme RightMed pharmacogenomic test identifies which prescription drugs are—or aren’t—likely to work based on your genetic makeup and current prescription interactions. Your physician will receive a clear, actionable report for personalizing your prescriptions.

The latest at OneOme

  • minnppst logo

Select partners

“Before OneOme, only those with deep financial resources or the critically ill could access the power of pharmacogenomics. Today, patients at Ridgeview can receive personalized prescription insights that previously were inaccessible to them. Not only will our patients see better health outcomes – they are also avoiding life-threatening adverse drug reactions, which are the fourth leading cause of death.”

- Bob Stevens, President and CEO of Ridgeview Medical Center


Precision medicine. Informed care.